A call for Smart Industry by CHIST-ERA on Big Data and Process Modelling A programme for European Coordinated Research on Long-term Information and Communication Technologies (ICT) and ICT-based scientific challenges, CHIST-ERA annually calls for research proposals on key emerging topics. In 2017, the brief was ‘Big Data and process modelling for smart industry’. Partnering with […]
Why MD Cybersecurity is so important? PQE Group – 3/12/2019 The hidden risks of a disruptive innovation. Is Cybersecurity important for Medical Devices? The answer is absolutely yes. But let’s move a bit backwards, to understand the reason why nowadays Cybersecurity has become a main concern for all Medical Devices producers. It’s well renowned that […]
On September 26th, 2019 the CMDh published the notice “Information on nitrosamines for marketing authorisation holders” asking to all Marketing Authorization Holders (MAHs) of human medicinal products containing chemically synthesised active pharmaceutical ingredients to evaluate the risk of the presence of nitrosamine impurities in their products. This includes generics and over-the counter (OTC) products.
PQE Group has been awarded for the 2nd year in a row, starring in ESG evaluation and business growth. Borsa Italiana (MI), Sept. 25th, 2019 – PQE Group received the Excellent Companies’ Award for 2019. For the company based in Reggello (Florence, Italy), and led by the founder and C.E.O. Gilda D’Incerti, this is the […]
PQE Group presented the documentary ‘Flying Dreams’ on the occasion of the “Festival of Culture – Summer Nights 2019” on the experience lived by the employees in a school in Kathmandu.
Project co-financed under Tuscany POR FESR 2014 – 2020 – Measure 1.1.5
PQE Group was the special guest for “Meet the Champions” event. PQE Group, selected among the excellent companies in Italy, told about its history last May 17 in Prato, through the words of the COO Claudio Puglisi on the occasion of the “Meet the Champions” event organized by Italy Post in collaboration with “L’Economia” of […]
FDA has issued setting temporary rules on a probable cancer-causing impurity formerly regulated. To avoid market shortage of Losartan, drugmakers will be able to make losartan with an impurity percentage above its prescribed level for six months while the supply of clean drugs is ramped up. A calculated risk, to preserve blood pressure drugs availability […]
PQE Group is glad to announce the opening of the new office in the city of Hyderabad (Telangana), India. Grand opening for the second office in India. The grand opening ceremony took place on April 16th 2019, in the presence of PQE Group management representatives: our C.E.O. Gilda D’Incerti, the C.O.O. Claudio Puglisi, PQE India […]
Blockchain is an increasingly widespread technology that is approaching a stage of maturity that could see an explosion of its use also in the health sector. The point of the situation has been published in “Blockchain in Healthcare Today (BHTY)”, which identifies the ten main trends of this evolution. Consolidation of startups and user education […]